Home LiteratureArticle Details
PMID: 7934410 Published · ppublish English Letter

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

Lancet (London, England) ·Vol. 344 ·No. 8928 ·1994-10-08 ·Pages 1025-6

Lynn WA, Clutterbuck E, Want S, Markides V, Lacey S, Rogers TR, Cohen J

Abstract

暂无摘要

MeSH Terms
Adult Aged Anti-Bacterial Agents/pharmacology,therapeutic use Enterococcus faecium/drug effects Female Gram-Positive Bacterial Infections/drug therapy,etiology Humans Male Middle Aged Peritoneal Dialysis, Continuous Ambulatory/adverse effects Peritonitis/drug therapy,microbiology Virginiamycin/therapeutic use
Chemicals
Anti-Bacterial Agents Virginiamycin quinupristin-dalfopristin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Lynn W A
Clutterbuck E
Want S
Markides V
Lacey S
Rogers T R
Cohen J
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(94)91687-x
Published
1994-10-08
Pages
1025-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(94)91687-x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2